BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17280616)

  • 1. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.
    Lin ML; Park JH; Nishidate T; Nakamura Y; Katagiri T
    Breast Cancer Res; 2007; 9(1):R17. PubMed ID: 17280616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrestin-3 interaction with maternal embryonic leucine-zipper kinase.
    Perry NA; Fialkowski KP; Kaoud TS; Kaya AI; Chen AL; Taliaferro JM; Gurevich VV; Dalby KN; Iverson TM
    Cell Signal; 2019 Nov; 63():109366. PubMed ID: 31352007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of MELK as a downstream of Del-1 and druggable targets in triple-negative breast cancer.
    Lee IH; Lee SJ; Kang B; Lee J; Jung JH; Park HY; Park JY; Park NJ; Kim EA; Kang J; Chae YS
    Breast Cancer Res Treat; 2024 May; 205(1):181-191. PubMed ID: 38279017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma.
    Cigliano A; Pilo MG; Mela M; Ribback S; Dombrowski F; Pes GM; Cossu A; Evert M; Calvisi DF; Utpatel K
    Medicina (Kaunas); 2019 Dec; 56(1):. PubMed ID: 31861475
    [No Abstract]   [Full Text] [Related]  

  • 5. Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses.
    Hameed Y
    J Cancer Res Ther; 2023 Oct; 19(7):1852-1864. PubMed ID: 38376289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer.
    Xie X; Chauhan GB; Edupuganti R; Kogawa T; Park J; Tacam M; Tan AW; Mughees M; Vidhu F; Liu DD; Taliaferro JM; Pitner MK; Browning LS; Lee JH; Shen Y; Wang J; Ueno NT; Krishnamurthy S; Hortobagyi GN; Tripathy D; Van Laere SJ; Bartholomeusz G; Dalby KN; Bartholomeusz C
    Cancer Res Commun; 2023 Jun; 3(6):1078-1092. PubMed ID: 37377604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the regulation of maternal embryonic leucine zipper kinase.
    Cao LS; Wang J; Chen Y; Deng H; Wang ZX; Wu JW
    PLoS One; 2013; 8(7):e70031. PubMed ID: 23922895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic lethal screen identifies HDAC4 as a potential target in MELK overexpressing cancers.
    Zhou L; Zheng S; Rosas Bringas FR; Bakker B; Simon JE; Bakker PL; Kazemier HG; Schubert M; Roorda M; van Vugt MATM; Chang M; Foijer F
    G3 (Bethesda); 2021 Dec; 11(12):. PubMed ID: 34550356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway.
    Janostiak R; Rauniyar N; Lam TT; Ou J; Zhu LJ; Green MR; Wajapeyee N
    Cell Rep; 2017 Dec; 21(10):2829-2841. PubMed ID: 29212029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function.
    Li Z; Zhou H; Zhai X; Gao L; Yang M; An B; Xia T; Du G; Li X; Wang W; Jin B
    Cell Death Dis; 2023 Nov; 14(11):733. PubMed ID: 37949877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis.
    Shimo A; Tanikawa C; Nishidate T; Lin ML; Matsuda K; Park JH; Ueki T; Ohta T; Hirata K; Fukuda M; Nakamura Y; Katagiri T
    Cancer Sci; 2008 Jan; 99(1):62-70. PubMed ID: 17944972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-Regulation of MELK Promotes Cell Growth and Invasion by Accelerating G1/S Transition and Indicates Poor Prognosis in Lung Adenocarcinoma.
    Ni Q; Miao Y; Li X; Yin Z; Huang H; Shi G; Shi W
    Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38676754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunity.
    Wang D; Zou F; Li Y; Hu J; Gao L
    Mol Ther Oncol; 2024 Mar; 32(1):200759. PubMed ID: 38596298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cells.
    Shimo A; Nishidate T; Ohta T; Fukuda M; Nakamura Y; Katagiri T
    Cancer Sci; 2007 Feb; 98(2):174-81. PubMed ID: 17233835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Molecule Functional Converter of B-Cell Lymphoma-2 (Bcl-2) Suppresses Breast Cancer Lung Metastasis.
    Kopparapu PR; Löhr CV; Pearce MC; Tyavanagimatt S; Nakshatri H; Kolluri SK
    ACS Pharmacol Transl Sci; 2024 May; 7(5):1302-1309. PubMed ID: 38751629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin: an inhibitor for a high-expressed BCL-2A1/BFL1 protein, linked with poor prognosis in breast cancer.
    Gupta SRR; Mittal P; Kundu B; Singh A; Singh IK
    J Biomol Struct Dyn; 2023 Oct; ():1-11. PubMed ID: 37837418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Maternal Embryonic Leucine Zipper Kinase Is Associated with Metastasis in Triple-negative Breast Cancer.
    Xie X; Chauhan GB; Edupuganti R; Kogawa T; Park J; Tacam M; Tan AW; Mughees M; Vidhu F; Liu DD; Taliaferro JM; Pitner MK; Browning LS; Lee JH; Bertucci F; Shen Y; Wang J; Ueno NT; Krishnamurthy S; Hortobagyi GN; Tripathy D; Van Laere SJ; Bartholomeusz G; Dalby KN; Bartholomeusz C
    Cancer Res Commun; 2024 Jan; 4(1):236. PubMed ID: 38282551
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer.
    Chung S; Suzuki H; Miyamoto T; Takamatsu N; Tatsuguchi A; Ueda K; Kijima K; Nakamura Y; Matsuo Y
    Oncotarget; 2012 Dec; 3(12):1629-40. PubMed ID: 23283305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells.
    Wang Y; Lee YM; Baitsch L; Huang A; Xiang Y; Tong H; Lako A; Von T; Choi C; Lim E; Min J; Li L; Stegmeier F; Schlegel R; Eck MJ; Gray NS; Mitchison TJ; Zhao JJ
    Elife; 2014 May; 3():e01763. PubMed ID: 24844244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal embryonic leucine zipper kinase (MELK): a novel regulator in cell cycle control, embryonic development, and cancer.
    Jiang P; Zhang D
    Int J Mol Sci; 2013 Oct; 14(11):21551-60. PubMed ID: 24185907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.